European Medicines Agency hosts meeting with European Parliament representatives
A delegation from the European Parliament's Committee on the Environment, Public Health and Food Safety (ENVI) has visited the European Medicines Agency to hear an update on its activities.
The meeting, held on Wednesday and Thursday this week, was part of ENVI's regular cycle of visits to the European Agencies under its remit. ENVI last visited the Medicines Agency in 2007.
The delegation included five Members of the European Parliament:
- Jo Leinen, Chair of ENVI
- Dagmar Roth-Behrendt, Member of ENVI
- Christofer Fjellner, Member of ENVI
- Peter Liese, Member of ENVI
- Linda McAvan, Member of ENVI
Topics included changes to European Union legislation on medicines, including the implementation of the pharmacovigilance legislation, new legislation on falsified medicines and information to patients, and proposals for changes to the laws on veterinary medicines.
There was an in-depth discussion on antimicrobial resistance and the reduced effectiveness of antibiotics due to high levels of use in humans and animals. The delegation also discussed conflicts of interest with the Agency's representatives.
The meeting provided an opportunity for discussion of topics of mutual interest between the European Parliament and the Agency, before the hearing of Guido Rasi, the Agency's new Executive Director-designate, in front of ENVI on Wednesday 13 July.